Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to $305000.0.

  • Ptc Therapeutics' Amortization of Deferred Charges rose 166.67% to $305000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 193.28%. This contributed to the annual value of $1.2 million for FY2024, which is 3603.84% down from last year.
  • Ptc Therapeutics' Amortization of Deferred Charges amounted to $305000.0 in Q3 2025, which was up 166.67% from $302000.0 recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Amortization of Deferred Charges ranged from a high of $585000.0 in Q4 2022 and a low of $295000.0 during Q2 2024
  • Over the past 5 years, Ptc Therapeutics' median Amortization of Deferred Charges value was $438000.0 (recorded in 2023), while the average stood at $406631.6.
  • As far as peak fluctuations go, Ptc Therapeutics' Amortization of Deferred Charges tumbled by 9204.39% in 2021, and later skyrocketed by 5039.37% in 2023.
  • Quarter analysis of 5 years shows Ptc Therapeutics' Amortization of Deferred Charges stood at $471000.0 in 2021, then rose by 24.2% to $585000.0 in 2022, then crashed by 48.89% to $299000.0 in 2023, then grew by 2.68% to $307000.0 in 2024, then decreased by 0.65% to $305000.0 in 2025.
  • Its Amortization of Deferred Charges was $305000.0 in Q3 2025, compared to $302000.0 in Q2 2025 and $299000.0 in Q1 2025.